HK1156532A1 - Urea-based film-forming solution for treating nail psoriasis - Google Patents

Urea-based film-forming solution for treating nail psoriasis

Info

Publication number
HK1156532A1
HK1156532A1 HK11110955A HK11110955A HK1156532A1 HK 1156532 A1 HK1156532 A1 HK 1156532A1 HK 11110955 A HK11110955 A HK 11110955A HK 11110955 A HK11110955 A HK 11110955A HK 1156532 A1 HK1156532 A1 HK 1156532A1
Authority
HK
Hong Kong
Prior art keywords
urea
based film
forming solution
nail psoriasis
treating nail
Prior art date
Application number
HK11110955A
Other languages
English (en)
Chinese (zh)
Inventor
‧謝努瓦
‧得洛怒瓦
‧庫貝泰爾格
‧勒弗朗索瓦茲
Original Assignee
皮埃爾‧法布爾皮膚化妝品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 皮埃爾‧法布爾皮膚化妝品公司 filed Critical 皮埃爾‧法布爾皮膚化妝品公司
Publication of HK1156532A1 publication Critical patent/HK1156532A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK11110955A 2008-10-21 2011-10-14 Urea-based film-forming solution for treating nail psoriasis HK1156532A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857146A FR2937250B1 (fr) 2008-10-21 2008-10-21 Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PCT/EP2009/063771 WO2010046375A1 (fr) 2008-10-21 2009-10-21 Solution à base d’urée formant un film pour le traitement du psoriasis des ongles

Publications (1)

Publication Number Publication Date
HK1156532A1 true HK1156532A1 (en) 2012-06-15

Family

ID=40823172

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110955A HK1156532A1 (en) 2008-10-21 2011-10-14 Urea-based film-forming solution for treating nail psoriasis

Country Status (24)

Country Link
US (1) US20110200544A1 (fr)
EP (1) EP2349243B1 (fr)
JP (1) JP2012506372A (fr)
KR (1) KR20110071118A (fr)
CN (1) CN102186468B (fr)
AR (1) AR074048A1 (fr)
AU (1) AU2009306462B2 (fr)
BR (1) BRPI0919833A2 (fr)
CA (1) CA2740001A1 (fr)
ES (1) ES2560178T3 (fr)
FR (1) FR2937250B1 (fr)
GE (1) GEP20135746B (fr)
HK (1) HK1156532A1 (fr)
IL (1) IL212372A0 (fr)
MA (1) MA32800B1 (fr)
MX (1) MX2011004016A (fr)
NZ (1) NZ592733A (fr)
PL (1) PL2349243T3 (fr)
PT (1) PT2349243E (fr)
RU (1) RU2508090C2 (fr)
TN (1) TN2011000167A1 (fr)
UA (1) UA102705C2 (fr)
WO (1) WO2010046375A1 (fr)
ZA (1) ZA201103437B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
WO2014159930A1 (fr) * 2013-03-14 2014-10-02 Alc Therapeutics, Llc Compositions antimycosiques pour le traitement de surinfections de la peau et des ongles
CN104758273B (zh) * 2015-04-09 2018-04-20 山东罗欣药业集团股份有限公司 一种尿素微囊制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
ATE320250T1 (de) * 2000-01-03 2006-04-15 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
AU2002248308B2 (en) * 2001-01-09 2006-12-07 Israel Dvoretzky Therapeutic film forming composition and treatment system
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6821508B2 (en) * 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
DK1423101T3 (da) * 2001-09-04 2011-05-23 Trommsdorff Arzneimittel Anvendelse af et plaster til behandlingen af onychomycosis
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
CA2492976C (fr) * 2002-09-05 2011-11-01 Galderma Research & Development, S.N.C. Solution destinee a une application ungueale et peri-ungueale
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
WO2005011565A2 (fr) * 2003-07-29 2005-02-10 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff

Also Published As

Publication number Publication date
KR20110071118A (ko) 2011-06-28
AU2009306462B2 (en) 2013-08-22
PL2349243T3 (pl) 2016-07-29
UA102705C2 (ru) 2013-08-12
GEP20135746B (en) 2013-02-11
IL212372A0 (en) 2011-06-30
RU2508090C2 (ru) 2014-02-27
AU2009306462A1 (en) 2010-04-29
CA2740001A1 (fr) 2010-04-29
EP2349243B1 (fr) 2015-11-11
PT2349243E (pt) 2016-03-14
WO2010046375A1 (fr) 2010-04-29
BRPI0919833A2 (pt) 2015-12-15
AR074048A1 (es) 2010-12-22
CN102186468A (zh) 2011-09-14
JP2012506372A (ja) 2012-03-15
US20110200544A1 (en) 2011-08-18
EP2349243A1 (fr) 2011-08-03
FR2937250A1 (fr) 2010-04-23
TN2011000167A1 (en) 2012-12-17
ES2560178T3 (es) 2016-02-17
FR2937250B1 (fr) 2013-05-10
RU2011119924A (ru) 2012-11-27
MA32800B1 (fr) 2011-11-01
CN102186468B (zh) 2014-02-12
NZ592733A (en) 2012-03-30
ZA201103437B (en) 2012-01-25
MX2011004016A (es) 2011-05-19

Similar Documents

Publication Publication Date Title
EP2244709A4 (fr) Formulations topiques pour le traitement du psoriasis
AU323792S (en) Spray applicator
IL209895A0 (en) Compounds for treating beta-amyloidoses
EP2334176A4 (fr) Formulations topiques pour le traitement d une neuropathie
EP2349480A4 (fr) Optimisations séquentielles pour planification de traitement
EP2314278A4 (fr) Composition de traitement capillaire
HK1203516A1 (en) Methods for treating psoriasis
IL225924A (en) Dlbcl treatment
HK1203305A1 (en) Methods for treating psoriasis
BR112013006232A2 (pt) processo de tratamento cosmético, composto e composição cosmética
IL225623A0 (en) Psoriasis treatment methods
EP2174914A4 (fr) Procédé de traitement du trioxyde de diarsenic
IL218633A0 (en) Methods for treating psoriasis
IL212212A0 (en) Compound useful for treating cellulite
GB0800145D0 (en) Skincare treatment
ZA200907349B (en) Method of treating hair
ZA201103061B (en) Stabilized composition for treating psoriasis
EP2624835A4 (fr) Compositions pour traiter le psoriasis du cuir chevelu
PL2538938T3 (pl) Kompozycja do leczenia grzybicy paznokci
HK1156532A1 (en) Urea-based film-forming solution for treating nail psoriasis
PL2318573T3 (pl) Sposób obróbki przeciwkorozyjnej
EP2240192A4 (fr) Traitement d&#39;états dermatologiques
ZA201005206B (en) Method of treating hair
GB2466110B (en) Antibacterial formulation for use in the treatment of acne
PL384259A1 (pl) Kompozycja farmaceutyczna do leczenia chorób skórnych

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171021